Activation of vagus nerve by semapimod alters substance P levels and decreases breast cancer metastasis

Regulatory Peptides

Volumn 179, Issue 1-3, 2012, Pages 101-108

  Erin, Nuray ^a   Duymuş, Özlem ^a   Öztürk, Saffet ^a   Demir, Necdet ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Afferent fibers; Capsaicin; CD10; Metastasis; Substance P; Vagus

Indexed keywords

ENALAPRIL; MEMBRANE METALLOENDOPEPTIDASE; SEMAPIMOD; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CARCINOMA CELL; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; IN VIVO STUDY; LIVER METASTASIS; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NERVE ENDING; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; SENSORY NERVE CELL; VAGOTOMY; VAGUS NERVE STIMULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CAPSAICIN; CELL LINE, TUMOR; FEMALE; HYDRAZONES; LIVER NEOPLASMS, EXPERIMENTAL; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEPRILYSIN; SENSORY RECEPTOR CELLS; SUBSTANCE P; VAGOTOMY; VAGUS NERVE;

ANIMALIA;

EID: 84867034800     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.08.001     Document Type: Article

References (48)

1. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357(9255):539-545.
2. de Visser K.E., Coussens L.M. The inflammatory tumor microenvironment and its impact on cancer development. Contrib. Microbiol. 2006, 13:118-137.
3. Pavlov V.A., Tracey K.J. The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005, 19(6):493-499.
4. Erin N., Akdas B.G., Harms J.F., Clawson G.A. Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level. Regul. Pept. 2008, 151(1-3):35-42.
5. Erin N., Boyer P.J., Bonneau R.H., Clawson G.A., Welch D.R. Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart. Anticancer. Res. 2004, 24(2B):1003-1009.
6. Bernik T.R., Friedman S.G., Ochani M., DiRaimo R., Ulloa L., Yang H., et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002, 195(6):781-788.
7. Molina P.E., Qian L., Schuhlein D., Naukam R., Wang H., Tracey K.J., Abumrad N.N. CNI-1493 attenuates hemodynamic and pro-inflammatory responses to LPS. Shock 1998, 10(5):329-334.
8. Denham W., Yang J., Wang H., Botchkina G., Tracey K.J., Norman J. Inhibition of p38 mitogen activate kinase attenuates the severity of pancreatitis-induced adult respiratory distress syndrome. Crit. Care Med. 2000, 28(7):2567-2572.
9. Martiney J.A., Rajan A.J., Charles P.C., Cerami A., Ulrich P.C., Macphail S., et al. Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent. J. Immunol. 1998, 160(11):5588-5595.
10. Meistrell M.E., Botchkina G.I., Wang H., Di S.E., Cockroft K.M., Bloom O., et al. Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock 1997, 8(5):341-348.
11. Palmblad K., Erlandsson-Harris H., Tracey K.J., Andersson U. Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis : a therapeutic study using a macrophage-deactivating compound. Am. J. Pathol. 2001, 158(2):491-500.
12. Kemeny M.M., Botchkina G.I., Ochani M., Bianchi M., Urmacher C., Tracey K.J. The tetravalent guanylhydrazone CNI-1493 blocks the toxic effects of interleukin-2 without diminishing antitumor efficacy. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(8):4561-4566.
13. Mori Y., Cai K., Cheng Y., Wang S., Paun B., Hamilton J.P., et al. A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterology 2006, 131(3):797-808.
14. Erin N., Zhao W., Bylander J., Chase G., Clawson G. Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells. Breast Cancer Res Treat 2006, 99(3):351-364.
15. Sternberg E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol. 2006, 6(4):318-328.
16. Kramer H.H., Schmidt K., Leis S., Schmelz M., Sommer C., Birklein F. Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation. Exp. Neurol. 2005, 195(1):179-184.
17. Terauchi M., Kajiyama H., Shibata K., Ino K., Mizutani S., Kikkawa F. Anti-progressive effect of neutral endopeptidase 24.11 (NEP/CD10) on cervical carcinoma in vitro and in vivo. Oncology 2005, 69(1):52-62.
18. Erin N., Clawson G.A. Parameters affecting substance P measurement in heart, lung, and skin. Biotechniques 2004, 37(2):232. 234, 236.
19. Erin N., Ulusoy O. Differentiation of neuronal from non-neuronal Substance P. Regul. Pept. 2009, 152(1-3):108-113.
20. Borovikova L.V., Ivanova S., Nardi D., Zhang M., Yang H., Ombrellino M., Tracey K.J. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton. Neurosci. 2000, 85(1-3):141-147.
21. Balkwill F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 2009, 9(5):361-371.
22. Kim S., Takahashi H., Lin W.W., Descargues P., Grivennikov S., Kim Y., et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 2009, 457(7225):102-106.
23. Ryuto M., Ono M., Izumi H., Yoshida S., Weich H.A., Kohno K., Kuwano M. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J. Biol. Chem. 1996, 271(45):28220-28228.
24. Samaniego F., Markham P.D., Gendelman R., Gallo R.C., Ensoli B. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J. Immunol. 1997, 158(4):1887-1894.
25. Yoshida S., Ono M., Shono T., Izumi H., Ishibashi T., Suzuki H., Kuwano M. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol. Cell. Biol. 1997, 17(7):4015-4023.
26. Cohen P.S., Nakshatri H., Dennis J., Caragine T., Bianchi M., Cerami A., Tracey K.J. CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(9):3967-3971.
27. Bjork L., Tracey K.J., Ulrich P., Bianchi M., Cohen P.S., Akerlund K., et al. Targeted suppression of cytokine production in monocytes but not in T lymphocytes by a tetravalent guanylhydrazone (CNI-1493). J. Infect. Dis. 1997, 176(5):1303-1312.
28. Leek R.D., Hunt N.C., Landers R.J., Lewis C.E., Royds J.A., Harris A.L. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J. Pathol. 2000, 190(4):430-436.
29. Pupa S.M., Bufalino R., Invernizzi A.M., Andreola S., Rilke F., Lombardi L., et al. Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas. J. Clin. Oncol. 1996, 14(1):85-94.
30. Miles D.W., Happerfield L.C., Naylor M.S., Bobrow L.G., Rubens R.D., Balkwill F.R. Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue. Int. J. Cancer 1994, 56(6):777-782.
31. Pusztai L., Clover L.M., Cooper K., Starkey P.M., Lewis C.E., McGee J.O. Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast. Br. J. Cancer 1994, 70(2):289-292.
32. Dixon M., Jackson D.M., Richards I.M. A study of the afferent and efferent nerve distribution to the lungs of dogs. Respiration 1980, 39(3):144-149.
33. Wehner S., Straesser S., Vilz T.O., Pantelis D., Sielecki T., de la Cruz V.F., Hirner A., Kalff J.C. Inhibition of p38 mitogen-activated protein kinase pathway as prophylaxis of postoperative ileus in mice. Gastroenterology 2009, 136(2):619-629.
34. The F., Cailotto C., van der Vliet J., de Jonge W.J., Bennink R.J., Buijs R.M., Boeckxstaens G.E. Central activation of the cholinergic anti-inflammatory pathway reduces surgical inflammation in experimental post-operative ileus. Br. J. Pharmacol. 2011, 163(5):1007-1016.
35. Coleridge J.C., Coleridge H.M. Afferent vagal C fibre innervation of the lungs and airways and its functional significance. Rev. Physiol. Biochem. Pharmacol. 1984, 99:1-110.
36. Dunzendorfer S., Wiedermann C.J. Neuropeptides and the immune system: focus on dendritic cells. Crit. Rev. Immunol. 2001, 21(6):523-557.
37. Okajima K., Harada N. Regulation of inflammatory responses by sensory neurons: molecular mechanism(s) and possible therapeutic applications. Curr. Med. Chem. 2006, 13(19):2241-2251.
38. Manske J.M., Hanson S.E. Substance-P-mediated immunomodulation of tumor growth in a murine model. Neuroimmunomodulation 2005, 12(4):201-210.
39. Korcum A.F., Sanlioglu S., Aksu G., Tuncel N., Erin N. Radiotherapy-induced decreases in substance P levels may potentiate melanoma growth. Mol Med Rep 2009, 2(2):319-326.
40. Sun N.N., Wong S.S., Keith I., Witten M.L. Tachykinin substance P depletion by capsaicin exacerbates inflammatory response to sidestream cigarette smoke in rats. Toxicology 2004, 201(1-3):39-50.
41. Iwata N., Tsubuki S., Takaki Y., Shirotani K., Lu B., Gerard N.P., et al. Metabolic regulation of brain Abeta by neprilysin. Science 2001, 292(5521):1550-1552.
42. El-Amouri S.S., Zhu H., Yu J., Marr R., Verma I.M., Kindy M.S. Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. Am. J. Pathol. 2008, 172(5):1342-1354.
43. Balog T., Marotti T., Abramic M., Beusan-Svoboda I., Sobocanec S., Hrsak I. Neutrophil neutral endopeptidase variation and its regulation by opioid peptides. Int. Immunopharmacol. 2001, 1(3):569-579.
44. Milligan E.D., O'Connor K.A., Armstrong C.B., Hansen M.K., Martin D., Tracey K.J., et al. Systemic administration of CNI-1493, a p38 mitogen-activated protein kinase inhibitor, blocks intrathecal human immunodeficiency virus-1 gp120-induced enhanced pain states in rats. J Pain 2001, 2(6):326-333.
45. Mendez C., Jaffray C., Wong V., Salhab K.F., Kramer A.A., Carey L.C., Norman J.G. Involvement of p38 mitogen-activated protein kinase in the induction of tolerance to hemorrhagic and endotoxic shock. J. Surg. Res. 2000, 91(2):165-170.
46. Scherberich A., Tucker R.P., Degen M., Brown-Luedi M., Andres A.C., Chiquet-Ehrismann R. Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro. Oncogene 2005, 24(9):1525-1532.
47. Specht S., Sarite S.R., Hauber I., Hauber J., Gorbig U.F., Meier C., et al. The guanylhydrazone CNI-1493: an inhibitor with dual activity against malaria-inhibition of host cell pro-inflammatory cytokine release and parasitic deoxyhypusine synthase. Parasitol. Res. 2008, 102(6):1177-1184.
48. Jasiulionis M.G., Luchessi A.D., Moreira A.G., Souza P.P., Suenaga A.P., Correa M., et al. Inhibition of eukaryotic translation initiation factor 5A (eIF5A) hypusination impairs melanoma growth. Cell Biochem Funct 2007, 25(1):109-114.